MaxiVac-FLU

Manufacturer: Intervet/Schering-Plough Animal Health

Swine Influenza Vaccine, Killed Virus

U.s. Vet. Lic. No.

165A

Contents

The vaccine contains a type A subtype H1N1 field isolate and is adjuvanted to enhance immunity. Field and laboratory data indicate that the vaccine is safe and effective in weaning age pigs, is safe for use in pregnant females at any stage of gestation, and provides immunity for at least three months following vaccination. Contains gentamicin and thimerosal as preservatives.

MaxiVac-FLU Indications

For the vaccination of healthy swine against swine influenza due to Type A H1N1 subtype.

MaxiVac-FLU Dosage And Administration

For use in swine only. Shake well and administer 2 mL intramuscularly. Pigs nursing non-immune dams can be safely and effectively vaccinated at weaning. Pigs from immune dams should be vaccinated when maternal antibody levels will allow active immunization. For primary vaccination, administer a second dose in 3 to 4 weeks.

Precaution(s)

Store at 35°-45°F (2°-7°C). Use entire contents when first opened.

MaxiVac-FLU Caution(s)

Anaphylactoid reactions may occur.

Antidote(s)

Epinephrine.

Warning(s)

Do not vaccinate within 21 days of slaughter.

P19003-10 / P19005-10

Presentation

10 dose (20 mL), 50 dose (100 mL), and 100 dose (200 mL) vials.

Nac No.

10472280